Diabetic Foot Ulcers Treatment Market

Global Diabetic Foot Ulcers Treatment Market Size, Share & Trends Analysis, By Treatment Type (Wound Care Dressing, Wound Care Devices, Active Therapies, and Others), By Type of Ulcer (Neuropathic Ulcers, Ischemic Ulcers, and Neuro-Ischemic Ulcers), By End-User (Hospitals, Clinics, Ambulatory Surgical Centers, and Homecare Settings), Forecast (2021-2027)

Published: Jan 2022 | Report Code: OMR2025456 | Category : Pharmaceuticals | Delivery Format: /

The global diabetic foot ulcers treatment market is expected to grow at a significant CAGR during the forecast period (2021-2027). Diabetic ulcers cause a considerable number of leg amputations across the globe, hence the demand for effective medicine and treatment to address this disease is increasing. In 2018, about 30 million people in the US had diabetes, with almost a quarter of those suffering from diabetic foot ulcers. According to the IDF (International Diabetes Federation), in 2019, the total adult population in the US with diabetes was 31.0 million while in Canada was 2.8 million. The US has the largest population of children and adolescents with type 1 diabetes (175,900). Moreover, there were around 189,000 mortalities due to diabetes in the US in 2019, which represents one of the highest numbers of mortalities around the globe. The increased prevalence of diabetes directly impacts the market growth as foot ulcers are a common complication of diabetes that is not managed by insulin treatment or other diabetes management. Around 25% of the diabetic patients experience foot ulcers, hence, with the increasing number of diabetic patients in the region, the number of patients with a foot ulcer will increase, which will create demand for the proper treatment methods.

Further, technological advancements will lead to the growth of the market in the country. For instance, in 2020, Siren, a smart socks developer raised $11.8 million in series B funding. Earlier to this, the company had raised $6.5 million in series A funding and $3.4 million in seed funding. The company offers commercial FDA-registered temperature monitoring socks. It can be connected wirelessly to a software application and allows podiatrists to detect early signs of inflammation in patients at risk of developing diabetic foot ulcers. The product enables real-time detection and early intervention, which can prevent serious complications. Diabetic foot ulcers affected roughly 169,000 people in the UK in 2019, according to the Diabetic Foot Journal. These startling figures imply that diabetic foot ulcers are becoming more common even in developed countries. 

Market Coverage

  • The market number available for – 2020-2027
  • Base year- 2020
  • Forecast period- 2021-2027
  • Segment Covered
  • Regions Covered- Globally

Competitive Landscape: 3M Co., Smith & Nephew Plc, and Coloplast A/S, among others. 

Key questions addressed by the report

  • What is the market growth rate?
  • Which segment and region dominates the market in base year?
  • Which segment and region will project fastest growth in the market?
  • How COVID-19 impacted the market?

o Recovery Timeline

o Deviation from pre-COVID forecast

o Most affected region and segment

  • Who is the leader in the market?
  • How players are addressing challenges to sustain growth?
  • Where is the investment opportunity?

Global Diabetic Foot Ulcers Treatment Market by Segment

By Treatment Type 

Wound Care Dressing

Wound Care Devices

Active Therapies

Others

By Type of Ulcer 

Neuropathic Ulcers 

Ischemic Ulcers

Neuro-Ischemic Ulcers

By End-user 

Hospitals 

Clinics

Ambulatory Surgical Centers

Homecare Settings

Global Diabetic Foot Ulcers Treatment Market by Region

North America

  • United States
  • Canada

Europe

  • UK
  • Germany
  • Italy
  • Spain
  • France
  • Rest of Europe 

Asia-Pacific

  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific 

Rest of the World